Fluoroquinolones in India&amp;#151;Are we prescribing it right: A cost variation study

Chawan, Vihang S.; Gawand, Kalpesh V.; Badwane, Sagar V.

doi:10.5455/njppp.2015.5.1604201547

Cited by 8 publications

(7 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5,6 Earlier studies have shown a wide variation in prices of the same drugs manufactured by different pharmaceutical companies. [7][8][9] As there is a paucity of data regarding the assessment of price variation among anxiolytic drugs, this study was planned to assess the price variation amongst different anxiolytic drugs available in Indian market.  The drug formulation being manufactured by only one pharmaceutical company or being manufactured by different pharmaceutical companies; however, in different strengths were excluded.…”

Section: Introductionmentioning

confidence: 99%

Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market

Chawan¹,

Badwane²,

Gawand³

et al. 2016

Int J Res Med Sci

Self Cite

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market

Chawan¹,

Badwane²,

Gawand³

et al. 2016

Int J Res Med Sci

Self Cite

View full text Add to dashboard Cite

“…The findings in our study show a percentage variation in cost above 100% for the available oral fluoroquinolones in India. The same situation was prevalent 3 years back when Chawan et al [10] had done a similar study. The situation has actually worsened with higher percentage variation today.…”

Section: Discussionmentioning

confidence: 60%

“…Very few studies have been done to evaluate the cost variation of drugs of different brands in India [4][5][6][7][8][9]. A cost variation study on flouroquinoloes was done 3 years back by Chawan et al [10] in 2015 which showed wide variation and highlighted prompt need for actions. Hence, a study was planned to see the cost variation of different brands of oral flouroquinolones and its combinations in India.…”

Section: Introductionmentioning

confidence: 99%

Cost Variation Analysis Study of Floroquinolones in India: Dilemma of the Prescribing Doctors “Which Brand To Choose?”

Pv¹,

Sk²

2020

SJMPS

View full text Add to dashboard Cite

Background: Prescriber plays a vital role of choosing the drug and its brand for the patient which affects the patient in terms of safety, efficacy as well as the cost. In India, the infectious diseases form the major burden. Flouroquinolones are one of the most prescribed antibiotics which provide therapeutic cure. The study aimed to see the cost variation of oral fluoroquinolones available in India. Methods: The costs of a particular oral flouroquinolones were obtained from CIMS and Drug Today for the same strength and dosage. Results: Of 25 drugs used as single drug therapy Levofoxacin (500 mg) showed highest price variation of 14526.87 % and only 6 had less than 100 % variation. Of the 10 types of combinations are available with 12 types of dosage forms. Maximum cost variation (390.63%) was seen with ofloxacin and ornidazole (200+500) combination. Conclusion: There is a wide cost variation among oral flouroquinolones which adds to the dilemma for the prescribing physician. There is a need to include pharmaco-economics in medical curriculum for sensitizing the doctors about cost of prescriptions and need for regulatory authorities to initiate measures to bring regularities in cost and monitor it.

show abstract

“…10 Previous studies report that the availability of a comparative manual of drug prices will aid in decision making and prescribing the economically cheaper drug to the patient and reduce unnecessary expenses on drugs. 13 The government of India's national pharmaceutical pricing authority has limited the highest price of medicines according to the drug price control order (DPCO 2020). 14 Pharmaceutical companies can fix the prices of their products below the ceiling prices as per DPCO.…”

Section: Resultsmentioning

confidence: 99%

Cost Variation Study of Various Brands of Oral Fluoroquinolones Available in India: An Economic Perspective

Hetawal

Gupta

et al. 2022

Pharmacology and Clinical Pharmacy Research (PCPR) is an intern

View full text Add to dashboard Cite

Fluoroquinolones are broad-spectrum antibacterial for treating respiratory tract, intra-abdominal, urinary tract, pelvic, joint, bone, soft tissue, and skin infections. The economic burden on patients affects compliance in developing countries like India. Therefore, the prices of drugs should be controlled effectively. Hence, this study was done to assess the cost variation of branded oral fluoroquinolones available in India compared with generic counterparts. The maximum and minimum cost of oral fluoroquinolones (INR per 10 tablets) of the same strength and dosage form manufactured by different companies was obtained from Drug Today April to July 2021 Volume 1, MIMS, and 1mg.com. The cost ratio and the percentage cost variation of individual drug brands were calculated. Prices of generic fluoroquinolones from the Jan Aushadhi scheme (JAS) were compared with branded drugs. Of 11 different oral fluoroquinolones, levofloxacin 500 mg had the highest percentage variation of 11.100%, and three formulations marketed by a few manufacturers have a percentage reduction of less than 100%. Of 23 different combinations available as 33 different dosages, the highest cost variations were observed in Norfloxacin 400 mg plus tinidazole 600 mg combination (1317%). When compared, some generic fluoroquinolones available under JAS were not cheaper than the minimum cost of their branded counterparts. Wide variation in the cost of the different brands of the same oral fluoroquinolones manufactured by other companies was observed. This adds to the economic burden for the patients. Hence, stakeholders should aim to decrease the cost variation among different brands while maintaining therapeutic efficacy

show abstract

Fluoroquinolones in IndiaAre we prescribing it right: A cost variation study

Cited by 8 publications

References 2 publications

Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market

Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market

Cost Variation Analysis Study of Floroquinolones in India: Dilemma of the Prescribing Doctors “Which Brand To Choose?”

Cost Variation Study of Various Brands of Oral Fluoroquinolones Available in India: An Economic Perspective

Contact Info

Product

Resources

About